ArticleAnnals of medicine and surgery (2012)2025

Delgocitinib 2% cream: a promising FDA-approved therapy for moderate-to-severe chronic hand eczema.

Zara Jawaid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.